Mind Medicine Mindmed Inc
(NQ:
MNMD
)
8.110
-0.270 (-3.22%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
832,390
Open
8.120
Bid (Size)
7.910 (1)
Ask (Size)
8.400 (5)
Prev. Close
8.380
Today's Range
7.870 - 8.370
52wk Range
2.410 - 12.22
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
July 31, 2024
Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy.
Via
Benzinga
MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer
July 29, 2024
From
Mind Medicine Inc.
Via
Business Wire
Performance
YTD
+124.03%
+124.03%
1 Month
+14.55%
+14.55%
3 Month
-12.04%
-12.04%
6 Month
+107.95%
+107.95%
1 Year
+86.44%
+86.44%
More News
Read More
MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)
July 17, 2024
From
Mind Medicine Inc.
Via
Business Wire
Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
July 14, 2024
Via
Talk Markets
3 Psychedelic Stocks to Ride to the Moon and Beyond
July 06, 2024
Via
InvestorPlace
Exposures
Product Safety
FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals
July 04, 2024
Via
InvestorPlace
Exposures
Product Safety
Clinical-Stage BioTech Drug Stocks Declined 13% In June
July 01, 2024
Via
Talk Markets
MindMed to be Included in Russell 2000® and Russell 3000® Indexes
June 28, 2024
From
Mind Medicine Inc.
Via
Business Wire
Groundbreaking Fentanyl Vaccine Being Developed To Prevent Fatal Overdoses, Startup Secures $10M
June 26, 2024
Via
Benzinga
Largest Clinical-Stage BioTech Drug Stocks Declined 6%
June 22, 2024
Via
Talk Markets
MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
June 21, 2024
From
Mind Medicine Inc.
Via
Business Wire
MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)
June 20, 2024
From
Mind Medicine
Via
Business Wire
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024
June 18, 2024
Via
InvestorPlace
Largest Psychedelic Compound Based Drug Stocks Fell 13% Last Week - Here's Why
June 09, 2024
Via
Talk Markets
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
June 05, 2024
Via
Benzinga
Exposures
Product Safety
What's Going On With MindMed And Psychedelic Stocks?
June 05, 2024
Via
Benzinga
DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 05, 2024
Via
Benzinga
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 05, 2024
Via
Benzinga
Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
June 05, 2024
Via
Benzinga
MindMed to Participate in June Conferences
May 28, 2024
From
Mind Medicine Inc.
Via
Business Wire
Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week
May 27, 2024
Via
Talk Markets
The Time Traveler’s Portfolio: 3 Stocks to Buy Now for Massive Returns by 2034
May 23, 2024
Via
InvestorPlace
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing
May 15, 2024
Via
Benzinga
Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
May 13, 2024
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.